Shelys is known not only providing quality products but also affordable generic and branded offerings across its areas of operation.  The products cover a wide spectrum of therapeutic segments of analgesics, cough and Cold, anti-infective, ointments, anti-infectives, gastro intestinal products, erectile dysfunction, cardiovascular, topical   and nutraceuticals.  The company’s products are well known and have wide acceptability throughout the sub Saharan region.

Shelys concentration is on the script market and is based in Tanzania its sister company Beta Healthcare based in Nairobi has its mainstay in OTC products, Infant milk formula and herbal supplements. In 2008 Aspen pharmaceuticals one of the largest pharmaceutical companies strategically acquired 100% of Shelys Africa leveraging on Shelys extensive distribution channel in sub Saharan market  and in turn ensuring Shelys Africa leverages on advance technological transfer


Shelys pharmaceutical in a bid to comply with the increasing market demand and strategic growth into export markets embarked on an expansion strategy by commissioning a new state of the art manufacturing plant that was WHO cGMP compliant. Shelys was the pioneer   in Tanzania to commission a world-class penicillin plant as per WHO cGMP and US FDA standards.  With this, Shelys became the first company in Tanzania to manufacture penicillin products locally. Shelys is built on a total area of 200,000 Sq.. The plant is first of its kind in East Africa, and uses the latest European standard Modular Clean Room Panels against the conventional Brick     walls.

Quality has been the hallmark of Shelys.  Major investment in technically qualified personnel, latest range of equipments combined with in-process systems and procedures ensures that the customer gets products better than the prescribed standards. The plant is equipped with modern automatic equipments for both solid & liquid orals preparations with full compliance to cGMP.